Aortic Valve Stenosis
Conditions
Brief summary
A single-center registry including all patients treated with TAVI at the Heart Center, Leipzig, Germany
Detailed description
A single-center registry including all patients treated with transcatheter aortic valve implantation (TAVI) at the Heart Center, Leipzig, Germany. Patients undergo a routine clinical and echocardiographic follow-up schedule, including a long-term follow-up plan up to 10 years to assess valve durability.
Interventions
DEVICETranscatheter Aortic Valve Implantation
Interventional replacement of the aortic valve
Sponsors
Helios Health Institute GmbH
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Inclusion criteria
* All patients treated with TAVI
Exclusion criteria
* None
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Mortality | Up to 10 years | Cardiovascular and not cardiovascular death 1. identify the current incidence of periprocedural complications. 2. identification of risk groups 3. description of the long-term outcome with special attention to the durability of the different prostheses |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Structural valve deterioration | Up to 10 years | Transposthetic mean pressure gradient ≥ 40mmHg and/or ≥20mmHg rise from baseline OR severe intraprosthetic aortic regurgitation |
Countries
Germany
Contacts
Primary ContactMohamed Abdel-Wahab, MD
Backup ContactHolger Thiele, MD
Outcome results
None listed